Log In
Print
BCIQ
Print
Print this Print this
 

SynCon DNA HBV vaccine (INO-1800)

  Manage Alerts
Collapse Summary General Information
Company Inovio Pharmaceuticals Inc.
DescriptionSynthetic DNA vaccine encoding a recombinant consensus plasmid from genotype A through E of the hepatitis B core antigen (HBcAg)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis B virus (HBV)
Indication DetailsPrevent HBV infection
Regulatory Designation

Partner

Roche


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today